Physician profile
Norman Melton
NPI 1013961069
$86,129.29
in general payments reported to CMS, 2019-2025
12 companies · $49K in 2025
The $49K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.77 · 2021: $15.75 · 2022: $6,322 · 2023: $16K · 2024: $15K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $69K · Travel and Lodging: $6,301 · Food and Beverage: $3,524 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $68,750.00 |
| Travel and Lodging | $6,301.34 |
| Food and Beverage | $3,524.12 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $83,689.17 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Thea Pharma INC. | $1,352.26 | 2023 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $395.98 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $165.44 | 2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $133.84 | 2022 | |
| Harrow Eye, LLC | $126.94 | 2024-2025 | Natacyn, Tobradex St, Verkazia |
| Alcon Vision LLC | $112.54 | 2022-2025 | Eysuvis, Tryptyr |
| Astellas Pharma US INC | $74.94 | 2023 | |
| Abbvie INC. | $24.31 | 2025 | |
| Mallinckrodt Hospital Products INC. | $22.35 | 2024 | Acthar |
| Eyevance Pharmaceuticals LLC | $15.77 | 2019 | |
| Kala Pharmaceuticals, INC. | $15.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Melton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.